ExpressionEdits and Boehringer Ingelheim partner to optimize gene therapies

cafead

Administrator
Staff member
  • cafead   Feb 14, 2025 at 09:22: AM
via UK-based biotechnology company ExpressionEdits has announced a partnership and licensing agreement with Boehringer Ingelheim for optimising the expression of gene therapies.

article source